These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6996025)

  • 1. The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations.
    Sjöqvist F
    Psychopharmacol Bull; 1980 Jul; 16(3):21-5. PubMed ID: 6996025
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring tricyclic antidepressant plasma levels.
    Sato TL; Madakasira S
    Am Fam Physician; 1984 May; 29(5):199-202. PubMed ID: 6731239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of tricyclic antidepressants in clinical practice.
    Hollister LE
    J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
    Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
    Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug level monitoring in psychopharmacology: usefulness and clinical problems, with special reference to tricyclic antidepressants.
    Gram LF; Pedersen OL; Kristensen CB; Bjerre M; Kragh-Sørensen P
    Ther Drug Monit; 1982; 4(1):17-25. PubMed ID: 7041335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring outpatients' plasma antidepressant-drug concentrations as a measure of compliance.
    Voris JC; Morin C; Kiel JS
    Am J Hosp Pharm; 1983 Jan; 40(1):119-20. PubMed ID: 6823984
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and clinical response to tricyclic antidepressants.
    Gram LF
    Acta Psychiatr Scand Suppl; 1980; 280():169-80. PubMed ID: 6996429
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of tricyclic antidepressant concentrations to determine individual response.
    Morin A; Stoukides CA
    Ann Pharmacother; 1993; 27(7-8):896-7. PubMed ID: 8364275
    [No Abstract]   [Full Text] [Related]  

  • 9. On the role of plasma level monitoring of tricyclic antidepressants in clinical practice.
    Asberg M; Sjöqvist F
    Commun Psychopharmacol; 1978; 2(5):381-91. PubMed ID: 738018
    [No Abstract]   [Full Text] [Related]  

  • 10. Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials.
    Glassman AH; Davis JM
    J Clin Psychopharmacol; 1993 Aug; 13(4):296-9. PubMed ID: 8376622
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma concentrations of tricyclic antidepressants in clinical practice.
    J Clin Psychiatry; 1982 Sep; 43(9):389-90. PubMed ID: 7118847
    [No Abstract]   [Full Text] [Related]  

  • 12. Some factors affecting the plasma levels of tricyclic antidepressants.
    Moyes IC; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():103-6. PubMed ID: 7393818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of methodological factors in determining the accuracy and precision of measurements of tricyclic antidepressant drug concentrations in serum.
    Wilson JF; Williams J; Marshall RW; Richens A; Dijkhuis IC; Harteveld AR; de Jong HJ
    Ther Drug Monit; 1986; 8(1):123-5. PubMed ID: 3961890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic monitoring of tricyclic antidepressant drugs].
    Grzesiak M; Beszłej JA; Szewczuk-Bogusławska M
    Psychiatr Pol; 2003; 37(5):825-37. PubMed ID: 14631602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of carbamazepine and carbamazepine 10,11-epoxide in the fluorescence polarization immunoassay for tricyclic antidepressants: estimation of the true tricyclic antidepressant concentration in the presence of carbamazepine using a mathematical model.
    Dasgupta A; McNeese C; Wells A
    Am J Clin Pathol; 2004 Mar; 121(3):418-25. PubMed ID: 15023047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring].
    Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A
    Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.